Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?


Eli Lilly & Co.

Eli Lilly & Co. (LLY)





Eli Lilly and Company is a drug manufacturing company. It discovers, develops, manufactures, and sells products in two business segments: human pharmaceutical products and animal health products.

Issuer Information

Exchange: NYSE
Market Cap: 61442662246
CEO: John C Lechleiter
Employees: 38350
Issuer Type: CS
Auditor: Ernst & Young LLP
Last Audit: UQ
CIK: 59478
Sector: Healthcare
Industry: Drug Manufacturers
Sub-Industry: Drug Manufacturers - Major
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: 2834
Last earning call url:
Slideshare slide url:

Contact Information

Main phone: +1 317 276-2000
Address: Lilly Corporate Center
Address 2: Drop Code 1112
State: IN
City / Town: Indianapolis
Postal Code: 46285


No public videos available.


No Result Found.


Pfenex ($PFNX) was a December 2009 spinout from The Dow Chemical Company (DOW) headquartered in San Diego, CA, Eleven other companies are scheduled for the week of July 14, 2014. The…
Ambrx ($AMBX) is a clinical stage biotechnology company focused on discovering and developing first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates. It is headquartered in La Jolla, CA. Fourteen other…
Billions of dollars have been spent chasing molecular targets in neurological diseases that now appear to be worthless. Effective therapies remain rare. But the market is enormous—and low risk—if a…
Shares of small-cap pharma Ariad Pharmaceuticals (ARIA) were trading higher on Friday after rumors were started by British paper The Daily Mail that Jazz Pharmaceuticals (JAZZ) was interested in acquiring…
Shares for biotech firms fell late in Friday’s trading session, throwing a damper on the strong buying that had characterized the day’s activity prior to 2pm. Stocks held on to…
Starting a new investment company and investing in very small biotechs can be a minefield. Because the business is fraught with bad science and liquidity traps, it takes insight and…
Wall Street closed lower today after a fairly brutal sell-off that kept all benchmark indices in the red for the entirety of the trading session, after what has been an…
Rumors that major pharmaceutical companies may be circling Ariad Pharmaceuticals (ARIA) regarding a potential buyout helped drive shares of the volatile stock higher on Thursday. Ariad was up over 11…
Shares in Rexahn Pharmaceuticals (RNN) jumped nearly 40 percent on Monday, continuing a bull-run that has the stock up over 150 percent since Thursday and over 265 percent in the…
The National Football League has taken big steps with rule changes, and fine incidence and costs in the last couple years to try and better protect players, especially from head…


No followers yet


About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.